Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- 12 February 2010
- journal article
- other
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 26 (3) , 173-178
Abstract
The aim of this study was to evaluate the effects of metformin in addition to diet and exercise on endocrine and metabolic disturbances in women with polycystic ovary syndrome (PCOS) in a prospective, double-blind, randomized, placebo (PBO) control trial. Thirty women with insulin resistance and PCOS received lifestyle modification and 1500 mg of metformin or placebo for 4 months. Before and after treatment, body mass index, waist/hip ratio, blood pressure, hirsutism, and menstrual patterns were evaluated. Serum concentrations of gonadotropins, androgens, progesterone, glucose, insulin, and lipids were measured. Lifestyle interventions resulted in similar weight and menstrual cycle's improvements in both groups. A significant reduction in serum fasting insulin, HOMA index, waist and testosterone levels was only observed with metformin. There were no significant changes in androstenedione, dehydroepiandrosterone sulfate, gonadotropins, and lipids levels. No other changes were observed in hirsutism or blood pressure. These findings suggest that metformin has an additive effect to diet and exercise to improve parameters of hyperandrogenism and insulin resistance. Although, a small decrease in body weight trough lifestyle changes could be enough to improve menstrual cycles in insulin-resistant women with PCOS.Keywords
This publication has 34 references indexed in Scilit:
- The metabolic syndrome—a new worldwide definitionThe Lancet, 2005
- Polycystic Ovary SyndromeNew England Journal of Medicine, 2005
- The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected PopulationThe Journal of Clinical Endocrinology & Metabolism, 2004
- Prevalence and Predictors of Coronary Artery Calcification in Women with Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2003
- Long-term health consequences of PCOSHuman Reproduction Update, 2002
- Prevalence and predictors of dyslipidemia in women with polycystic ovary syndromeThe American Journal of Medicine, 2001
- A Survey of the Polycystic Ovary Syndrome in the Greek Island of Lesbos: Hormonal and Metabolic ProfileThe Journal of Clinical Endocrinology & Metabolism, 1999
- Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.Diabetes Care, 1999
- A Direct Effect of Hyperinsulinemia on Serum Sex Hormone-Binding Globulin Levels in Obese Women with the Polycystic Ovary Syndrome*The Journal of Clinical Endocrinology & Metabolism, 1991
- Insulin Stimulates Androgen Accumulation in Incubations of Ovarian Stroma Obtained from Women with Hyperandrogenism*The Journal of Clinical Endocrinology & Metabolism, 1986